• network 13 home
  • providers
  • patients
  • FDA Medwatch
  • Complaints and Grievance Page
  • Dialysis Facility Compare
  • Patient Rights & Responsibilities
  • Disaster Readiness
  • Network Patient
    Representative Program
  • Upcoming Events for Patients
  • Other Patient Resources
  • Patient Advocacy Committee
  • Kidney Community Gatherings
  • Returning to Work (Vocational Rehabilitation)
  • Patient Newsletter
  • Medicare Information
  • Support Groups
  • Contact Us

ESRD Network 13 Medwatch Database

To Search the ESRD Network 13 FDA Medwatch Database click here.

ESRD's FDA Medwatch Listing
05/20/2013 FDA MedWatch - All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
05/20/2013 FDA MedWatch - Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
05/17/2013 FDA MedWatch - Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
05/16/2013 FDA MedWatch - April 2013 Safety Labeling Changes includes 48 products with revisions to Prescribing Information
05/09/2013 FDA MedWatch - The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products
05/01/2013 FDA MedWatch - Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK Unit By Fenwal: Recall - Labeling Issue Identified
04/30/2013 FDA MedWatch - Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution
04/29/2013 FDA MedWatch - Hospira Inc., GemStar Infusion System: Recall - Lithium Battery Low Voltage
04/26/2013 FDA MedWatch - Sodium Chloride Injection 0.9 percent USP, 100 mL Flexible Containers by Hospira: Recall - Particulate Matter
04/25/2013 FDA MedWatch - LifeScan, Inc.OneTouch Verio IQ Blood Glucose Meter - Recall: Failure to provide a warning at extremely high blood glucose levels
Next Last

 



Privacy Policy | Contact Us | Site Map

© 2013 FMQAI: ESRD Network 13. All rights reserved.
FMQAI: Network 13's Bylaws, Articles of Incorporation and Conflict of Interest Policy are available for review from the Network office.

This material was prepared by ESRD Network 13 under the Centers for Medicare & Medicaid Services (CMS) Contract Number HHSM-500-2013-NW013C. The contents presented do not necessarily reflect CMS policy, nor imply endorsement by the U.S. Government.